gatifloxacin has been researched along with Coronary Artery Disease in 4 studies
Gatifloxacin: A fluoroquinolone antibacterial agent and DNA TOPOISOMERASE II inhibitor that is used as an ophthalmic solution for the treatment of BACTERIAL CONJUNCTIVITIS.
gatifloxacin : A monocarboxylic acid that is 4-oxo-1,4-dihydroquinoline-3-carboxylic acid which is substituted on the nitrogen by a cyclopropyl group and at positions 6, 7, and 8 by fluoro, 3-methylpiperazin-1-yl, and methoxy groups, respectively. Gatifloxacin is an antibiotic of the fourth-generation fluoroquinolone family, that like other members of that family, inhibits the bacterial topoisomerase type-II enzymes.
Coronary Artery Disease: Pathological processes of CORONARY ARTERIES that may derive from a congenital abnormality, atherosclerotic, or non-atherosclerotic cause.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Neopterin is a soluble marker of monocyte activation, and elevated levels are of prognostic value in patients with stable coronary artery disease." | 5.12 | Long-term prognostic value of neopterin: a novel marker of monocyte activation in patients with acute coronary syndrome. ( Braunwald, E; Cannon, CP; Morrow, DA; Ray, KK; Rifai, N; Sabatine, MS; Shui, A, 2007) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Muhlestein, JB | 1 |
| Taylor-Robinson, D | 1 |
| Boman, J | 1 |
| Brogan, SE | 1 |
| Cahalan, MK | 1 |
| Ray, KK | 1 |
| Morrow, DA | 1 |
| Sabatine, MS | 1 |
| Shui, A | 1 |
| Rifai, N | 1 |
| Cannon, CP | 1 |
| Braunwald, E | 1 |
1 review available for gatifloxacin and Coronary Artery Disease
| Article | Year |
|---|---|
Antibiotic treatment of atherosclerosis.
Topics: Animals; Anti-Bacterial Agents; Arteriosclerosis; Azithromycin; C-Reactive Protein; Cardiovascular D | 2003 |
1 trial available for gatifloxacin and Coronary Artery Disease
| Article | Year |
|---|---|
Long-term prognostic value of neopterin: a novel marker of monocyte activation in patients with acute coronary syndrome.
Topics: Acute Disease; Anti-Infective Agents; Anticholesteremic Agents; Atorvastatin; Biomarkers; Coronary A | 2007 |
2 other studies available for gatifloxacin and Coronary Artery Disease
| Article | Year |
|---|---|
The failure of antibiotics to prevent heart attacks.
Topics: Anti-Bacterial Agents; Azithromycin; Chlamydophila Infections; Chlamydophila pneumoniae; Coronary Ar | 2005 |
Gatifloxacin as a possible cause of serious postoperative hypoglycemia.
Topics: Anti-Infective Agents; Blood Glucose; Cardiac Surgical Procedures; Cardiopulmonary Bypass; Coronary | 2005 |